Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Adverse effects
Systematic review 3-armed trial	30 people admitted to hospital with advanced AIDS Data from 1 RCT	Extrapyramidal adverse effects with haloperidol	The review assessed adverse effects using the Extrapyramidal Symptom Rating Scale, because of consensus that extrapyramidal effects are likely to be seen with neuroleptic drugs acting on dopaminergic receptors. No participants taking haloperidol developed dyskinetic or dystonic symptoms, and there was no increase in parkinsonism